http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106212442-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106212442-B |
| titleOfInvention | A kind of de- cell cornea stand-by protection liquid |
| abstract | The present invention provides a kind of de- cell cornea preparation protection liquid, is PBS the or HBSS buffer for being added with 5-12g/L hyaluronic acid, 5~20g/L chondroitin sulfate, 3~10g/L low molecular weight dextran.The present invention adds protectiveness ingredient in basis buffer; the colloid osmotic pressure for enabling the protection liquid of preparation that de- cell cornea to be maintained to prepare liquid by the selection of component and proportion; compared with traditional de- cell cornea prepares liquid, can be significantly reduced the extracellular matrix components such as collagen the later period take off in cell treatment process be excessively swollen, lose caused by corneal transparence decline；And the antibiotic compositions such as addition tobramycin, inhibit the bacteria breed of easy infection cornea, such as Pseudomonas aeruginosa, klebsiella bacillus, Enterobacter, proteus, avoids the pollution probability in treatment process. |
| priorityDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.